Selexipag treatment for pulmonary arterial hypertension associated with congenital heart disease after defect correction: insights from the randomised controlled GRIPHON study

Maurice Beghetti, Richard N. Channick, Kelly M. Chin, Lilla Di Scala, Sean Gaine, Hossein Ardeschir Ghofrani, Marius M. Hoeper, Irene M. Lang, Vallerie V. McLaughlin, Ralph Preiss, Lewis J. Rubin, Gérald Simonneau, Olivier Sitbon, Victor F. Tapson, Nazzareno Galiè

Research output: Contribution to journalArticlepeer-review

11 Scopus citations

Fingerprint Dive into the research topics of 'Selexipag treatment for pulmonary arterial hypertension associated with congenital heart disease after defect correction: insights from the randomised controlled GRIPHON study'. Together they form a unique fingerprint.

Medicine & Life Sciences